Published: Wed, May 30, 2018
Medicine | By Douglas Stevenson

Allergan recalls birth control pills; packaging error could lead to unintended pregnancies

Allergan recalls birth control pills; packaging error could lead to unintended pregnancies

Allergan PLC is recalling almost 170,000 sample packs of its birth-control treatment Taytulla after placebo and active capsules were placed out of order, potentially raising the risk of an unintended pregnancy.

They say the pack should have 24 capsules with hormones followed by four maroon capsules without hormones.

Pharmaceutical company Allergan issued a voluntary nationwide recall Tuesday on nearly 170,000 sample packs of the birth control Taytulla.

Women who take the oral contraceptive out of sequence may have a higher risk of contraceptive failure and thus unintended pregnancy. The packs affected by the recall belong to Lot# 5620706, Expiration May-2019 of Taytulla (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules) 1mg/20mcg, 6x28 physicians sample pack. If patients have concerns regarding the possibility of an unintended pregnancy they should consult their physician.

The drugmaker said Tuesday the physician sample packs of Taytulla were created to have 24 active birth control pills, followed by four placebo pills, taken daily over the course of 28 days.

The company says users may not notice that the pack has reversed the order.

The voluntary recall, issued late Tuesday, affects packages of Allergan's Taytulla contraceptive pills. This product was distributed Nationwide to healthcare providers.

Consumers with the recalled packs can contact their doctor about a return. Patients who received a sample pack should notify their physician to arrange for a return.

Anyone with questions about the recall can call Allergan at 800-678-1605.

Like this: